A successful blood borne virus (BBV) opt-out testing programme is being expanded across NHS Greater Manchester emergency ...

Indaptus Therapeutics (INDP) has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use ...

Fourth quarter and full year 2024 BRIUMVI U.S. net revenue of $103.6 million and $310 million, respectivelyTarget guidance of approximately $540 ...

Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps ...

Viral infections are a predominant cause of liver disease around the world, impacting millions with conditions ranging from mild inflammation to severe ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

In this piece, we include reporting tips, how vaccine side effects are tracked in the U.S., and what research shows about the ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

The CSIC-UNESPA scientific expedition has been underway since last January with the aim of monitoring the presence of the highly pathogenic avian influenza virus (HPAI H5N1) in Antarctica.

Antivirus apps for your PC protect your personal information, data, bank accounts, and much more. We've tested more than two dozen utilities to help you choose the best antivirus for your needs ...

If untreated, it can lead to late-stage HIV or Aids, the name for a collection of illnesses caused by the virus. Hepatitis B and Hepatitis C cause inflammation of the liver and come from viral ...